8 research outputs found
Histamine can be Formed and Degraded in the Human and Mouse Heart
Histamine is metabolized by several enzymes in vitro and in vivo. The relevance of this
metabolism in the mammalian heart in vivo is unclear. However, histamine can exert
positive inotropic effects (PIE) and positive chronotropic effects (PCE) in humans via H2-
histamine receptors. In transgenic mice (H2-TG) that overexpress the human H2 receptor in
cardiomyocytes but not in wild-type littermate mice (WT), histamine induced PIE and PCE
in isolated left or right atrial preparations. These H2-TG were used to investigate the
putative relevance of histamine degrading enzymes in the mammalian heart. Histidine, the
precursor of histamine, increased force of contraction (FOC) in human atrial preparations.
Moreover, histamine increased the phosphorylation state of phospholamban in human
atrium. Here, we could detect histidine decarboxylase (HDC) and histamine itself in
cardiomyocytes of mouse hearts. Moreover, our data indicate that histamine is subject
to degradation in the mammalian heart. Inhibition of the histamine metabolizing enzymes
diamine oxidase (DAO) and monoamine oxidase (MAO) shifted the concentration response
curves for the PIE in H2-TG atria to the left. Moreover, activity of histamine metabolizing
enzymes was present in mouse cardiac samples as well as in human atrial samples. Thus,
drugs used for other indication (e.g. antidepressants) can alter histamine levels in the heart.
Our results deepen our understanding of the physiological role of histamine in the mouse
and human heart. Our findings might be clinically relevant because we show enzyme
targets for drugs to modify the beating rate and force of the human heart
Monoclonal antibodies for human and porcine histamine N-methyltransferase (HMT) facilitate protein expression and localization studies
Diets high in heat-treated soybean meal reduce the histamine-induced epithelial response in the colon of weaned piglets and increase epithelial catabolism of histamine.
We examined the influence of dietary fermentable protein (fCP) and fermentable carbohydrates (fCHO) on the colonic epithelial response to histamine in pigs. Thirty-two weaned piglets were fed 4 diets in a 2 × 2 factorial design with low fCP/low fCHO, low fCP/high fCHO, high fCP/low fCHO and high fCP/high fCHO. After 21-23 days, the pigs were killed and tissue from the proximal colon was stimulated with carbachol, histamine, PGE2 or sodium hydrogen sulphide in Ussing chambers. Changes in short-circuit current and tissue conductance were measured. Diamine oxidase, histamine N-methyltransferase, stem cell growth factor receptor, Fc-epsilon receptor I and cystic fibrosis transmembrane conductance regulator gene expression was determined. Activities of diamine oxidase and histamine N-methyltransferase and numbers of colonic mast cells were measured. The change in the short-circuit current in response to histamine was lower (P = 0.002) and tended to be lower for PGE2 (P = 0.053) in high fCP groups compared to low fCP groups, irrespective of fCHO. Additionally, the change in tissue conductance after the application of histamine was lower (P = 0.005) in the high fCP groups. The expression of histamine N-methyltransferase mRNA (P = 0.033) and the activities of diamine oxidase (P = 0.001) and histamine N-methyltransferase (P = 0.006) were higher with high fCP in comparison with low fCP. The expression of mast cell markers, stem cell growth factor receptor (P = 0.005) and Fc-epsilon receptor I (P = 0.049) was higher with high fCP diets compared to diets low in fCP, whereas the mast cell count did not differ between groups. The expression of the cystic fibrosis transmembrane conductance regulator was reduced (P = 0.001) with high fCP diets compared to low fCP diets. The lower epithelial response to histamine and PGE2 and elevated epithelial histamine inactivation suggests an adaptation to high fCP diets
Gluconate-Lactobionate-Dextran Perfusion Solutions Attenuate Ischemic Injury and Improve Function in a Murine Cardiac Transplant Model
Static cold storage is the cheapest and easiest method and current gold standard to store and preserve donor organs. This study aimed to compare the preservative capacity of gluconate-lactobionate-dextran (Unisol) solutions to histidine-tryptophan-ketoglutarate (HTK) solution. Murine syngeneic heterotopic heart transplantations (Balb/c-Balb/c) were carried out after 18 h of static cold storage. Cardiac grafts were either flushed and stored with Unisol-based solutions with high-(UHK) and low-potassium (ULK) ± glutathione, or HTK. Cardiac grafts were assessed for rebeating and functionality, histomorphologic alterations, and cytokine expression. Unisol-based solutions demonstrated a faster rebeating time (UHK 56 s, UHK + Glut 44 s, ULK 45 s, ULK + Glut 47 s) compared to HTK (119.5 s) along with a better contractility early after reperfusion and at the endpoint on POD 3. Ischemic injury led to a significantly increased leukocyte recruitment, with similar degrees of tissue damage and inflammatory infiltrate in all groups, yet the number of apoptotic cells tended to be lower in ULK compared to HTK. In UHK- and ULK-treated animals, a trend toward decreased expression of proinflammatory markers was seen when compared to HTK. Unisol-based solutions showed an improved preservative capacity compared with the gold standard HTK early after cardiac transplantation. Supplemented glutathione did not further improve tissue-protective properties
Methodological approaches to investigate the effects of histamine receptor targeting compounds in preclinical models of breast cancer
Numerous studies demonstrated the pivotal role of histamine in breast cancer development and progression. This chapter aims to describe different preclinical breast cancer models, including in vitro soft agar clonogenic assay and in vivo chemically induced breast tumors in rats, human triple negative breast cancer (TNBC) xenograft, and murine TNBC syngeneic graft in mice. All these models could be useful and complementary to assess the role of histamine receptor ligands in breast cancer, which could originate advances in novel therapeutics to treat this disease. This chapter also describes the gold standard radiometric techniques to evaluate the activity of histamine metabolizing enzymes in breast cancer specimens.Fil: Martinel Lamas, Diego José. Pontificia Universidad Católica Argentina "Santa María de los Buenos Aires". Instituto de Investigaciones Biomédicas. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas; ArgentinaFil: Nicoud, Melisa Beatriz. Pontificia Universidad Católica Argentina "Santa María de los Buenos Aires". Instituto de Investigaciones Biomédicas. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas; ArgentinaFil: Sterle, Helena Andrea. Pontificia Universidad Católica Argentina "Santa María de los Buenos Aires". Instituto de Investigaciones Biomédicas. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas; ArgentinaFil: Cricco, Graciela Patricia. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Fisicomatemática. Cátedra de Física; ArgentinaFil: Martin, Gabriel Alejandro. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Fisicomatemática. Cátedra de Física; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Cremaschi, Graciela Alicia. Pontificia Universidad Católica Argentina "Santa María de los Buenos Aires". Instituto de Investigaciones Biomédicas. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas; ArgentinaFil: Schwelberger, Hubert G.. Medical University Innsbruck; AustriaFil: Rivera, Elena Susana. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Fisicomatemática. Cátedra de Física; ArgentinaFil: Medina, Vanina Araceli. Pontificia Universidad Católica Argentina "Santa María de los Buenos Aires". Instituto de Investigaciones Biomédicas. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas; Argentin
Histamine can be Formed and Degraded in the Human and Mouse Heart
Histamine is metabolized by several enzymes in vitro and in vivo. The relevance of this
metabolism in the mammalian heart in vivo is unclear. However, histamine can exert
positive inotropic effects (PIE) and positive chronotropic effects (PCE) in humans via H2-
histamine receptors. In transgenic mice (H2-TG) that overexpress the human H2 receptor in
cardiomyocytes but not in wild-type littermate mice (WT), histamine induced PIE and PCE
in isolated left or right atrial preparations. These H2-TG were used to investigate the
putative relevance of histamine degrading enzymes in the mammalian heart. Histidine, the
precursor of histamine, increased force of contraction (FOC) in human atrial preparations.
Moreover, histamine increased the phosphorylation state of phospholamban in human
atrium. Here, we could detect histidine decarboxylase (HDC) and histamine itself in
cardiomyocytes of mouse hearts. Moreover, our data indicate that histamine is subject
to degradation in the mammalian heart. Inhibition of the histamine metabolizing enzymes
diamine oxidase (DAO) and monoamine oxidase (MAO) shifted the concentration response
curves for the PIE in H2-TG atria to the left. Moreover, activity of histamine metabolizing
enzymes was present in mouse cardiac samples as well as in human atrial samples. Thus,
drugs used for other indication (e.g. antidepressants) can alter histamine levels in the heart.
Our results deepen our understanding of the physiological role of histamine in the mouse
and human heart. Our findings might be clinically relevant because we show enzyme
targets for drugs to modify the beating rate and force of the human heart
Histamine can be Formed and Degraded in the Human and Mouse Heart
Histamine is metabolized by several enzymes in vitro and in vivo. The relevance of this
metabolism in the mammalian heart in vivo is unclear. However, histamine can exert
positive inotropic effects (PIE) and positive chronotropic effects (PCE) in humans via H2-
histamine receptors. In transgenic mice (H2-TG) that overexpress the human H2 receptor in
cardiomyocytes but not in wild-type littermate mice (WT), histamine induced PIE and PCE
in isolated left or right atrial preparations. These H2-TG were used to investigate the
putative relevance of histamine degrading enzymes in the mammalian heart. Histidine, the
precursor of histamine, increased force of contraction (FOC) in human atrial preparations.
Moreover, histamine increased the phosphorylation state of phospholamban in human
atrium. Here, we could detect histidine decarboxylase (HDC) and histamine itself in
cardiomyocytes of mouse hearts. Moreover, our data indicate that histamine is subject
to degradation in the mammalian heart. Inhibition of the histamine metabolizing enzymes
diamine oxidase (DAO) and monoamine oxidase (MAO) shifted the concentration response
curves for the PIE in H2-TG atria to the left. Moreover, activity of histamine metabolizing
enzymes was present in mouse cardiac samples as well as in human atrial samples. Thus,
drugs used for other indication (e.g. antidepressants) can alter histamine levels in the heart.
Our results deepen our understanding of the physiological role of histamine in the mouse
and human heart. Our findings might be clinically relevant because we show enzyme
targets for drugs to modify the beating rate and force of the human heart